FundedIQ
Biotechnology

4D Path: Funding, Investors & Team (Oct 2026)

4D Path focuses on merging the fields of cancer diagnostics and precision medicine through a single quantitative digital platform that relies solely on a hematoxylin and eosin sample. Its technology is patented and designed to be comprehensive, allowing for the identification of underlying fundamental processes across various cancer types in multiple organ systems. The company was established in Belmont, Massachusetts in 2016.

www.4dpath.com Belmont, United States 1-10 employees
Total raised
$13.0M
Rounds
1
Latest
Undisclosed round
May 2023

4D Path has raised $13.0M across 1 funding round on record, the most recent an undisclosed round of $13.0M announced in May 2023.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

4D Path Company Profile and Key Stats

Total funding raised
$13.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$13.0M in May 2023
Employees
1-10
reported band
Headquarters
Belmont, United States

Latest funding round on record: May 2023.

4D Path Funding Rounds

Date
Round
Amount
Undisclosed round
$13.0M

4D Path Founders and Leadership Team

Name
Role
Contact
Satabhisa Mukhopadhyay
Founder
—

No contact details are on record for this team yet.

4D Path Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

4D Path's latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like 4D Path in Biotechnology and Belmont

Companies Similar to 4D Path

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

4D Path Funding FAQs

What does 4D Path do?

4D Path focuses on merging the fields of cancer diagnostics and precision medicine through a single quantitative digital platform that relies solely on a hematoxylin and eosin sample. Its technology is patented and designed to be comprehensive, allowing for the identification of underlying fundamental processes across various cancer types in multiple organ systems. The company was established in Belmont, Massachusetts in 2016.

How much funding has 4D Path raised?

4D Path has raised $13.0M across 1 round on record. The most recent is an undisclosed round of $13.0M announced in May 2023.

When did 4D Path last raise funding?

4D Path's most recent funding round on record is an undisclosed round of $13.0M, announced in May 2023.

Who founded 4D Path?

FundedIQ lists Satabhisa Mukhopadhyay (Founder) at 4D Path.

Where is 4D Path headquartered?

4D Path is based in Belmont, Massachusetts, United States.

How many employees does 4D Path have?

4D Path is in the 1-10 employee band.

How does 4D Path's funding compare to other Biotechnology startups?

4D Path's latest round of $13.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's 4D Path Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 4D Path is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.